Advertisement
ejvese
Journal Home
Search for

Volume 37, Issue 5, Pages 538-543 (May 2009)


View previous. 8 of 31 View next.

Effect of Postoperative Restrictive Fluid Therapy in the Recovery of Patients with Abdominal Vascular Surgery

J.A. González-FajardoaCorresponding Author Informationemail address, L. Mengibara, J.A. Brizuelaa, J. Castrodezab, C. Vaquero-Puertaa

Received 13 November 2008; accepted 20 January 2009. published online 23 February 2009.

Abstract 

Objective

To compare the outcome of the postoperative administration of a restricted or standard intravenous fluid regimen in patients who underwent elective abdominal vascular surgery. The primary end point was postoperative hospital stay.

Design

Prospective observer-blinded, randomised controlled trial.

Material and methods

Patients were considered eligible if they underwent transperitoneal aorto-iliac approach with infrarenal graft repair. During the operation and intensive care unit stay, fluids were prescribed by the anaesthetists who were unaware of the details of the study. In the vascular surgical ward, patients in the standard group (SG) received 2500ml of fluids per day, whereas patients in the restricted group (RG) received 1500ml of fluids per day. All the patients were evaluated on an intention-to-treat basis.

Results

Forty patients were randomised to the RG (n=20) or SG (n=20). No significant differences were observed in the recovery of gastrointestinal function. However, the postoperative hospital stay was shorter in the RG (8 days) than in the SG (12 days) (p=0.003).

Conclusions

The use of a restrictive postoperative fluid protocol significantly reduces the duration of hospital stay in patients who have undergone major elective abdominal vascular surgery.

a Division of Angiology and Vascular Surgery, Hospital Clínico Universitario of Valladolid, Avda. Ramón y Cajal, s/n 47003 Valladolid, Spain

b Department of Preventive Medicine, Hospital Clínico Universitario of Valladolid, Avda. Ramón y Cajal, s/n 47003 Valladolid, Spain

Corresponding Author InformationCorresponding author. Tel.: +34 9 83 248569; fax: +34 9 83 257511.

PII: S1078-5884(09)00046-X

doi:10.1016/j.ejvs.2009.01.010


View previous. 8 of 31 View next.